The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 25, 2015

Filed:

Dec. 19, 2013
Applicants:

Pascale Pouzet, Biberach an der Riss, DE;

Ralf Anderskewitz, Laupheim, DE;

Horst Dollinger, Schemmerhofen, DE;

Dennis Fiegen, Biberach an der Riss, DE;

Thomas Fox, Biberach an der Riss, DE;

Rolf Goeggel, Ulm, DE;

Christoph Hoenke, Biberach an der Riss, DE;

Domnic Martyres, Biberach an der Riss, DE;

Peter Nickolaus, Warthausen, DE;

Klaus Klinder, Oggelshausen, DE;

Inventors:

Pascale Pouzet, Biberach an der Riss, DE;

Ralf Anderskewitz, Laupheim, DE;

Horst Dollinger, Schemmerhofen, DE;

Dennis Fiegen, Biberach an der Riss, DE;

Thomas Fox, Biberach an der Riss, DE;

Rolf Goeggel, Ulm, DE;

Christoph Hoenke, Biberach an der Riss, DE;

Domnic Martyres, Biberach an der Riss, DE;

Peter Nickolaus, Warthausen, DE;

Klaus Klinder, Oggelshausen, DE;

Assignee:

Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 495/04 (2006.01); A61K 31/519 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
C07D 495/04 (2013.01); A61K 31/519 (2013.01);
Abstract

Dihydrothienopyrimidinesulphoxides of formula 1 wherein X is SO or SO, Ris H or C-alkyl, Ris H or an organic group as disclosed herein, and Ris an optionally substituted, mono- or bicyclic, unsaturated, partially saturated or saturated heterocycle or an optionally substituted, mono- or bicyclic heteroaryl, and the pharmacologically acceptable salts thereof, as well as pharmaceutical compositions which contain these compounds. These dihydrothienopyrimidinesulphoxides are suitable for the treatment of respiratory or gastrointestinal complaints or diseases, inflammatory diseases of the joints, skin or eyes, diseases of the peripheral or central nervous system, or cancers.


Find Patent Forward Citations

Loading…